ETF comparison

FHLC vs IBB

Both Healthcare.

Fidelity MSCI Health Care Index ETF · iShares Biotechnology ETF

Holdings overlap

Weighted by ISIN/CUSIP
17.8 %

151 positions appear in both funds. Buying equal dollars of FHLC and IBB would leave roughly 17.8% of each dollar exposed to the same underlying securities.

FHLC only 82.1% Shared 17.8% IBB only 91.9%
In FHLC only
187 positions
Shared
151 positions
In IBB only
105 positions

Side by side

FHLC

Fidelity MSCI Health Care Index ETF

Fidelity · Healthcare

79 composite / 100
Expense ratio
0.084%
Net assets
$3.22B
TTM yield
1.32%
Top-10 conc.
50.6%
IBB

iShares Biotechnology ETF

iShares · Healthcare

69 composite / 100
Expense ratio
0.44%
Net assets
$9.09B
TTM yield
0.22%
Top-10 conc.
54.7%

Sub-score comparison

92
Cost
56
83
Tax efficiency
85
79
Liquidity
98
42
Concentration
36
Tracking quality
FHLC sub-score IBB

Tracking quality isn't part of the composite — see what we don't score for why.

Cost difference

FHLC is 36 bps cheaper than IBB. On a $100,000 position that's about $356/yr more in fees for IBB.

Fee figure is the annual expense charged on $100,000. To see how the gap compounds over a multi-decade holding period, open the cost calculator pre-filled with FHLC vs IBB.

Top shared holdings

151 shared in total
# Holding In FHLC In IBB Overlap
1 Amgen Inc 3.01% 7.51% 3.01%
2 Gilead Sciences Inc 2.62% 7.75% 2.62%
3 Vertex Pharmaceuticals Inc 1.75% 7.44% 1.75%
4 Regeneron Pharmaceuticals Inc 1.18% 7.21% 1.18%
5 Alnylam Pharmaceuticals Inc 0.66% 3.99% 0.66%
6 Insmed Inc 0.47% 3.20% 0.47%
7 Biogen Inc 0.45% 2.46% 0.45%
8 Natera Inc 0.44% 2.41% 0.44%
9 United Therapeutics Corp 0.38% 2.30% 0.38%
10 Revolution Medicines Inc 0.38% 1.54% 0.38%
11 Illumina Inc 0.31% 1.68% 0.31%
12 Moderna Inc 0.26% 1.68% 0.26%

Only in FHLC

187 total
  • Eli Lilly & Co 12.13%
  • Johnson & Johnson 8.94%
  • AbbVie Inc 6.03%
  • UnitedHealth Group Inc 5.42%
  • Merck & Co Inc 4.38%
  • Thermo Fisher Scientific Inc 2.91%
  • Intuitive Surgical Inc 2.62%
  • Abbott Laboratories 2.55%
  • Pfizer Inc 2.45%
  • Bristol-Myers Squibb Co 1.99%

Only in IBB

105 total
  • BlackRock Funds III 9.66%
  • Argenx SE 3.07%
  • BeOne Medicines Ltd. 1.93%
  • Genmab A/S 1.17%
  • Ascendis Pharma A/S 0.96%
  • BioNTech SE 0.66%
  • Abivax SA 0.50%
  • Arcellx, Inc. 0.47%
  • Amicus Therapeutics, Inc. 0.41%
  • Centessa Pharmaceuticals plc 0.25%

Open FHLC or IBB at a brokerage

Both funds trade commission-free at major US brokerages.

Affiliate links — opening an account through these earns PlainIndex a one-time referral. Scoring is computed before any affiliate consideration; see our methodology and funding disclosure.

Holdings overlap is the sum of min(weight_a, weight_b) over positions matched on ISIN (CUSIP fallback). Methodology: see /methodology/.

Comparing two funds doesn't endorse swapping one for the other. Tax-lot history, account type, and personal goals matter — PlainIndex publishes data and methodology, not investment advice.